Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer. Inoue Y, Fujishima M, Ono M, Masuda J, et al. Breast Cancer Res Treat 2022 Sep 24. pii: 10.1007/s10549-022-06726.

Read + Share

Amedeo Smart

Independent Medical Education

Inoue Y, Fujishima M, Ono M, Masuda J, et al. Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer. Breast Cancer Res Treat 2022 Sep 24. pii: 10.1007/s10549-022-06726.
PMID: 36153381